Gouda MA, Voss MH, Tawbi H, Gordon M, Tykodi SS, Lam ET, Vaishampayan U, Tannir NM, Chaves J, Nikolinakos P, Fan A, Lee R, McDermott D, Shapiro GI, Gandhi L, Bhatia S, Katragadda V, Meric-Bernstam F. A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancer. ESMO Open. 2025 May; 10(5):104536.

Pio L, Bruno T, Godzinski J, Ehrlich PF, Cost N, Davidoff AM, Irtan S, Pachl M, Abu-Zaid A, Abdelhafeez AH, Losty PD. Comparison of open and minimally invasive nephrectomy for Wilms tumor: a systematic review and meta-analysis from the International Society of Pediatric Surgical Oncology. Pediatr Surg Int. 2025 Apr 16; 41(1):117.

Acker SN, Ziogas IA, Cost N, Cooper E, Farooqui Z, Eason CR, Vaughn AE, Dawson-Gore C, Somers KM, Fineman SL, Vangi S, Carter MM, Hartman SJ, Kotagal M. Association of Systemic Inflammatory Markers and Clinical Outcomes Among Children With Wilms Tumor. Pediatr Blood Cancer. 2025 Jul; 72(7):e31715.

Powles T, Choueiri TK, Albiges L, Peltola K, de Velasco G, Burotto M, Suarez C, Ghatalia P, Iacovelli R, Lam ET, Verzoni E, G?m?s M, Stadler WM, Kollmannsberger C, Melichar B, Venugopal B, Gross-Goupil M, Poprach A, De Santis M, Rizzo M, Shinde R, Saretsky TL, He L, Perini RF, Vickery D, Rini B. Health-related quality of life with belzutifan versus everolimus for advanced renal cell carcinoma (LITESPARK-005): patient-reported outcomes from a randomised, open-label, phase 3 trial. Lancet Oncol. 2025 Apr; 26(4):491-502.

Carbonara U, Ditonno F, Beksac AT, Derweesh I, Cerrato C, Celia A, Costa G, Bianchi L, Elbich J, Wilson B, Hampton LJ, Pandolfo SD, Basile G, Kim FJ, Schiavina R, Capitanio U, Kaouk J, Autorino R. Percutaneous Cryotherapy and Radiofrequency Ablation of Renal Masses: Multicenter Comparative Analysis with Minimum 3-Year Follow-up. Int Braz J Urol. 2025 Mar-Apr; 51(2).

Valverde P, Velasquez T, Ortiz R, Fuentes-Alabi SL, Pe?a A, Gonzalez JF, Gutierrez TL, Melendez LE, Tome E, Arreola M, Valsecchi MG, Colombo V, Luna-Fineman S, Blanco-Lopez J, Metzger ML, Spreafico F. Challenges and Opportunities of a Multi-Institutional Treatment Guideline for Wilms Tumor in Low-Middle-Income Countries-A Report From the Asociaci?n de Hemato-Oncolog?a Pedi?trica de Centro Am?rica (AHOPCA). Pediatr Blood Cancer. 2025 May; 72(5):e31616.

Bischoff ME, Shamsaei B, Yang J, Secic D, Vemuri B, Reisz JA, D'Alessandro A, Bartolacci C, Adamczak R, Schmidt L, Wang J, Martines A, Venkat J, Tcheuyap VT, Biesiada J, Behrmann CA, Vest KE, Brugarolas J, Scaglioni PP, Plas DR, Patra KC, Gulati S, Landero Figueroa JA, Meller J, Cunningham JT, Czyzyk-Krzeska MF. Copper Drives Remodeling of Metabolic State and Progression of Clear Cell Renal Cell Carcinoma. Cancer Discov. 2025 Feb 07; 15(2):401-426.

Szymanski KW, Pessoa RR, Kim JK, Buchanan AF, Hecht SL, Walker JP, Cost NG. Lymph Node Sampling in Pediatric Renal Tumors: Survey of Current Practices and Impact of Education. Urology. 2025 Feb; 196:222-227.

Panian J, Saidian A, Hakimi K, Ajmera A, Anderson WJ, Barata P, Berg S, Signoretti S, Lee Chang S, D'Andrea V, George D, Dzimitrowicz H, El Zarif T, Emamekhoo H, Gross E, Kilari D, Lam E, Lashgari I, Psutka S, Rauterkus GP, Shabaik A, Thapa B, Wang L, Weise N, Yim K, Zhang T, Derweesh I, McKay RR. Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy. Oncologist. 2024 Oct 03; 29(10):870-877.

Choueiri TK, Powles T, Peltola K, de Velasco G, Burotto M, Suarez C, Ghatalia P, Iacovelli R, Lam ET, Verzoni E, G?m?s M, Stadler WM, Kollmannsberger C, Melichar B, Venugopal B, Gross-Goupil M, Poprach A, De Santis M, Schutz FA, Park SH, Nosov DA, Porta C, Lee JL, Garcia-Del-Muro X, Biscaldi E, Manneh Kopp R, Oya M, He L, Wang A, Perini RF, Vickery D, Albiges L, Rini B. Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma. N Engl J Med. 2024 08 22; 391(8):710-721.